Exploiting pleiotropic activities of semaphorins as multi-target therapies for cancer

EMBO Molecular Medicine

Volumn 4, Issue 3, 2012, Pages 168-170

  Moserle, Lidia ^a   Casanovas, Oriol ^a  

^a CATALAN INSTITUTE OF ONCOLOGY   (Spain)

Author keywords

Anti cancer therapies; Semaphorins; Tumor angiogenesis; Tumor invasion; Tumor metastasis

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; FURIN; NEUROPILIN; PLEXIN; SEMAPHORIN; VASCULOTROPIN RECEPTOR 2;

ANTIANGIOGENIC THERAPY; CANCER GROWTH; CANCER INVASION; CARCINOGENESIS; CELL ADHESION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; DRUG TARGETING; ENDOCYTOSIS; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; METASTASIS; NEOPLASM; NOTE; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN CLEAVAGE; SIGNAL TRANSDUCTION; TUMOR CELL;

ANIMALS; CELL PROLIFERATION; FEMALE; FURIN; HUMANS; NEOPLASMS; SEMAPHORINS;

EID: 84858140242     PISSN: 17574676     EISSN: 17574684     Source Type: Journal    
DOI: 10.1002/emmm.201200206     Document Type: Note

References (9)

1. Capparuccia L, Tamagnone L (2009) Semaphorin signaling in cancer cells and in cells of the tumor microenvironment-two sides of a coin. J Cell Sci 122: 1723-1736.
2. Casazza A, Finisguerra V, Capparuccia L, Camperi A, Swiercz JM, Rizzolio S, Rolny C, Christensen C, Bertotti A, Sarotto I, et al (2010) Sema3E-Plexin D1 signaling drives human cancer cell invasiveness and metastatic spreading in mice. J Clin Invest 120: 2684-2698.
3. Casazza A, Kigel B, Maione F, Capparuccia L, Kessler O, Giraudo E, Mazzone M, Neufeld G, Tamagnone L (2012) Tumor growth inhibition and anti-metastatic activity of a mutated furin-resistant semaphorin 3E isoform. EMBO Mol Med DOI: 10.1002/emmm.201100205.
4. Christensen C, Ambartsumian N, Gilestro G, Thomsen B, Comoglio P, Tamagnone L, Guldberg P, Lukanidin E (2005) Proteolytic processing converts the repelling signal Sema3E into an inducer of invasive growth and lung metastasis. Cancer Res 65: 6167-6177.
5. Ebos JML, Kerbel RS (2011) Antiangiogenic therapy: impact on invasion, disease progression, and metastasis. Nat Rev Clin Oncol 8: 210-221.
6. Paez-Ribes M, Allen E, Hudock J, Takeda T, Okuyama H, Vinals F, Inoue M, Bergers G, Hanahan D, Casanovas O (2009) Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell 15: 220-231.
7. Roodink I, Verrijp K, Raats J, Leenders WP (2009) Plexin D1 is ubiquitously expressed on tumor vessels and tumor cells in solid malignancies. BMC Cancer 9: 297.
8. Sakurai A, Gavard J, Annas-Linhares Y, Basile JR, Amornphimoltham P, Palmby TR, Yagi H, Zhang F, Randazzo PA, Li X, et al (2010) Semaphorin 3E initiates antiangiogenic signaling through plexin D1 by regulating Arf6 and R-Ras. Mol Cell Biol 30: 3086-3098.
9. Serini G, Maione F, Giraudo E, Bussolino F (2009) Semaphorins and tumor angiogenesis. Angiogenesis 12: 187-193.